3 Top No-Brainer Stocks to Buy Todayby Mark Eisenberg 21.04.2024UiPath, a major player in the industry, has a massive market opportunity ahead. Despite a downturn, the stock is undervalued, ...
$100K+ Bitcoin Predicted by Pompliano, But Brace for a Dipby John Darbie 19.04.2024Bitcoin's value is projected to remain stable and not dip below $50,000, thanks to algorithmic trading. The current price is ...
XRP Bulls: Analyst Predicts Explosive Surge to $288by John Darbie 19.04.2024XRP's price movement resembles 2017, suggesting potential for significant growth. A forecast predicts a potential $288 value, with the possibility ...
Huge AI Funding Leads to Hype and ‘Grifting’ Warningby Lilu Anderson 09.04.2024AI is both overhyped and underhyped, says an expert. The excessive speculation clouds the phenomenal science and research, leading to ...
CORE Token Surges 280%: What’s Fueling the Rally?by John Darbie 07.04.2024An anonymous individual plans to increase the price of #CORE to $100 before the Bitcoin halving, which many believe is ...
Nvidia & Alphabet: Billionaire Cliff Asness Bets on AI Stocksby Lilu Anderson 31.03.2024Nvidia, a leader in AI chips, has a big investment from Asness, owning 1,671,007 shares valued at over $1.5 billion. ...
Cathie Wood Believes Palantir Could Outpace Microsoftby Mark Eisenberg 31.03.2024Wood has a large position in Palantir through her ETFs, as the company grows its customer base by 35% annually. ...
What Trump DJT and Reddit stock deals mean for the marketby Mark Eisenberg 30.03.2024An 80-year-old woman's financial well-being is a concern as her health deteriorates. Analysts discuss the potential impact of the Trump ...
Bitcoin Set for Parabolic Rally Soon, Says Trader – Timeline Revealedby John Darbie 30.03.2024Bitcoin hits new all-time high at $70,000, defying typical price patterns. Despite current dip, experts predict a major upward move. ...
Congressional Plans for WuXi: Implications for Biotechby Lilu Anderson 29.03.2024Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...